Evidence map›Paper›PMID 38797162›Full record

ArticleORL; journal for oto-rhino-laryngology and its related specialties2024

Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19.

Brandon J Vilarello, Patricia T Jacobson, Clayton J Snyder, Tse-Hwei Choo, Liam W Gallagher, Francesco F Caruana, Jeremy P Tervo, Joseph B Gary, Tiana M Saak, David A Gudis and 4 more

Abstract read
In one paragraph

Article in ORL; journal for oto-rhino-laryngology and its related specialties, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Brandon J VilarelloColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA, bjv2120@cumc.columbia.edu.
Patricia T JacobsonDepartment of Otolaryngology-Head and Neck Surgery, New York-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
Clayton J SnyderDivision of Mental Health Data Science, New York State Psychiatric Institute, New York, New York, USA.
Tse-Hwei ChooDivision of Mental Health Data Science, New York State Psychiatric Institute, New York, New York, USA.
Liam W GallagherColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Francesco F CaruanaColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Jeremy P TervoColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Joseph B GaryColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Tiana M SaakColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
David A GudisColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Paule V JosephNational Institute of Alcohol Abuse and Alcoholism, Section of Sensory Science and Metabolism and National Institute of Nursing Research, Bethesda, Maryland, USA.
Terry E GoldbergDepartment of Psychiatry, New York-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
Devangere P DevanandColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Jonathan B OverdevestColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Sensory Science and Metabolism; Molecular and Neuronal Mechanisms ZIAAA000136 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI JOSEPH, PAULE · 2021 to 2025
$3.2M
The Brief Research in Aging and Interdisciplinary NeurosciencesT35AG044303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sachin Agarwal, Jennifer Jaie Manly · 2013 to 2026
$1.9M
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19K23DC019678 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OVERDEVEST, JONATHAN B · 2021 to 2025
$893k
Chemosensation and COVID-19ZIAAA000138 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI JOSEPH, PAULE · 2022 to 2024
$188k
NCATS NIH HHS UL1 TR001873NIA NIH HHS T35 AG044303NIDCD NIH HHS K23 DC019678
6 · The paper itself

Abstract

introductionOlfactory dysfunction is a common symptom of COVID-19. However, subjective perception of olfactory function does not always correlate well with more objective measures. This study seeks to clarify associations between subjective and psychophysical measures of olfaction and gustation in patients with subjective chemosensory dysfunction following COVID-19.

methodsAdults with persistent COVID-19-associated chemosensory disturbance were recruited for a prospective, longitudinal cohort study at a tertiary care institution. Participants provided subjective measures of olfactory and gustatory function and underwent psychophysical assessment using Sniffin' Sticks olfactory and Monell gustatory tests.

resultsData analysis (n = 65) showed a statistically significant association between subjective and psychophysical measures of olfaction (p < 0.001). For each one-point increase in subjectively-reported olfactory ability, there is, on average, a 0.11 (95% CI: 0.06, 0.16; p < 0.001) point increase in TDI score while adjusting for age at baseline assessment, sex, and follow-up time. For each one-point increase in subjectively-reported olfactory ability, there is, on average, a 0.04 (95% CI: 0.02, 0.06; p < 0.001) point and 0.05 (95% CI: 0.03, 0.07; p < 0.001) point increase in discrimination and identification scores, respectively, when adjusting for age at baseline assessment, sex, and follow-up time.

conclusionSubjective olfaction shows a mild to moderate association with psychophysical measures, but it fails to comprehensively assess persistent COVID-19-associated chemosensory deficits. The lack of significant association between subjective olfaction and threshold limits the utility of subjective olfaction in tracking recovery. These findings support the push for more widespread psychophysical chemosensory testing.

Indexed as

COVID-19Olfaction DisordersAdultAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesPsychophysicsSARS-CoV-2SmellTaste DisordersCOVID-19GustationOlfactionPsychophysical testing

Identifiers

PMID38797162
PMCPMC11585663

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.